4.73 USD
+0.15 (+3.28%)
4.75 USD
+0.02 (+0.42%)
Taking everything into account, BLDE scores 4 out of 10 in our fundamental rating. BLDE was compared to 22 industry peers in the Passenger Airlines industry. While BLDE has a great health rating, there are worries on its profitability. BLDE is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year BLDE has reported negative net income.
In the past year BLDE had a positive cash flow from operations.
BLDE had negative earnings in each of the past 5 years.
BLDE had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -7.36%, BLDE is doing worse than 65.22% of the companies in the same industry.
BLDE has a Return On Equity (-8.51%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.36% | ||
| ROE | -8.51% | ||
| ROIC | N/A |
ROA(3y)-12.68%
ROA(5y)-33.09%
ROE(3y)-15.39%
ROE(5y)-48.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 25.01%, BLDE is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BLDE has grown nicely.
The Profit Margin and Operating Margin are not available for BLDE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 25.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.59%
GM growth 5YN/A
2. Health
2.1 Basic Checks
BLDE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BLDE has been increased compared to 1 year ago.
The number of shares outstanding for BLDE has been increased compared to 5 years ago.
BLDE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
BLDE has an Altman-Z score of 6.88. This indicates that BLDE is financially healthy and has little risk of bankruptcy at the moment.
BLDE's Altman-Z score of 6.88 is amongst the best of the industry. BLDE outperforms 95.65% of its industry peers.
BLDE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.88 |
ROIC/WACCN/A
WACC9.44%
2.3 Liquidity
BLDE has a Current Ratio of 5.95. This indicates that BLDE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.95, BLDE belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
BLDE has a Quick Ratio of 5.95. This indicates that BLDE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.95, BLDE belongs to the best of the industry, outperforming 95.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.95 | ||
| Quick Ratio | 5.95 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 62.12% over the past year.
The Revenue has been growing slightly by 6.70% in the past year.
BLDE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 70.13% yearly.
EPS 1Y (TTM)62.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y70.13%
Revenue growth 5YN/A
Sales Q2Q%4.2%
3.2 Future
BLDE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.77% yearly.
The Revenue is expected to grow by 26.27% on average over the next years. This is a very strong growth
EPS Next Y64.16%
EPS Next 2Y27.05%
EPS Next 3Y24.23%
EPS Next 5Y41.77%
Revenue Next Year7.5%
Revenue Next 2Y7.32%
Revenue Next 3Y7.57%
Revenue Next 5Y26.27%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
BLDE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BLDE. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
BLDE's earnings are expected to grow with 24.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.05%
EPS Next 3Y24.23%
5. Dividend
5.1 Amount
BLDE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
4.73
+0.15 (+3.28%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change7.64%
Market Cap386.44M
Revenue(TTM)254.34M
Net Income(TTM)-18.98M
Analysts85.45
Price Target7.91 (67.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)26.79%
Min EPS beat(2)-11.41%
Max EPS beat(2)64.99%
EPS beat(4)2
Avg EPS beat(4)16.68%
Min EPS beat(4)-24.95%
Max EPS beat(4)64.99%
EPS beat(8)4
Avg EPS beat(8)-21.68%
EPS beat(12)6
Avg EPS beat(12)-13.54%
EPS beat(16)9
Avg EPS beat(16)-24.3%
Revenue beat(2)2
Avg Revenue beat(2)8.01%
Min Revenue beat(2)7.7%
Max Revenue beat(2)8.32%
Revenue beat(4)3
Avg Revenue beat(4)4.72%
Min Revenue beat(4)-1.39%
Max Revenue beat(4)8.32%
Revenue beat(8)6
Avg Revenue beat(8)3.41%
Revenue beat(12)10
Avg Revenue beat(12)5.68%
Revenue beat(16)14
Avg Revenue beat(16)11.59%
PT rev (1m)7.64%
PT rev (3m)7.64%
EPS NQ rev (1m)-79.16%
EPS NQ rev (3m)-80.94%
EPS NY rev (1m)-16.07%
EPS NY rev (3m)4.41%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-0.94%
Revenue NY rev (1m)2.03%
Revenue NY rev (3m)2.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.52 | ||
| P/FCF | N/A | ||
| P/OCF | 298.87 | ||
| P/B | 1.73 | ||
| P/tB | 2.34 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)0.02
OCFY0.33%
SpS3.11
BVpS2.73
TBVpS2.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.36% | ||
| ROE | -8.51% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 25.01% | ||
| FCFM | N/A |
ROA(3y)-12.68%
ROA(5y)-33.09%
ROE(3y)-15.39%
ROE(5y)-48.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.59%
GM growth 5YN/A
F-Score6
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 331.71% | ||
| Cap/Sales | 8.19% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.95 | ||
| Quick Ratio | 5.95 | ||
| Altman-Z | 6.88 |
F-Score6
WACC9.44%
ROIC/WACCN/A
Cap/Depr(3y)198.6%
Cap/Depr(5y)143.5%
Cap/Sales(3y)4.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y64.16%
EPS Next 2Y27.05%
EPS Next 3Y24.23%
EPS Next 5Y41.77%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y70.13%
Revenue growth 5YN/A
Sales Q2Q%4.2%
Revenue Next Year7.5%
Revenue Next 2Y7.32%
Revenue Next 3Y7.57%
Revenue Next 5Y26.27%
EBIT growth 1Y62.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year130.57%
EBIT Next 3Y41.77%
EBIT Next 5Y38.84%
FCF growth 1Y53.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y103.19%
OCF growth 3YN/A
OCF growth 5YN/A
BLADE AIR MOBILITY INC / BLDE FAQ
Can you provide the ChartMill fundamental rating for BLADE AIR MOBILITY INC?
ChartMill assigns a fundamental rating of 4 / 10 to BLDE.
What is the valuation status of BLADE AIR MOBILITY INC (BLDE) stock?
ChartMill assigns a valuation rating of 1 / 10 to BLADE AIR MOBILITY INC (BLDE). This can be considered as Overvalued.
Can you provide the profitability details for BLADE AIR MOBILITY INC?
BLADE AIR MOBILITY INC (BLDE) has a profitability rating of 1 / 10.
Can you provide the financial health for BLDE stock?
The financial health rating of BLADE AIR MOBILITY INC (BLDE) is 8 / 10.